3.2. Synthesis
3.2.1. Reactions of Allyl Halides with Triflamide in the Presence NBS + MeCN
To solution of 1 g (6.7 mmol) of triflamide and 6.7 mmol of allyl halide 1, 2 in 30 mL of acetonitrile added 1.19 g (6.7 mmol) of NBS and reaction mixture was stirred in the dark for 24 h. Solvent was removed in vacuum, then the succinimide was precipitated with diethyl ether, filtered off, and ether removed in a vacuum. Analytically pure samples of substances were separated by column chromatography (0.063–0.2 mm, Acros Organics, Waltham, MA, USA). From the hexane–ether = 1:1 eluate, not reacted triflamide and dibromides were isolated, and from the diethyl ether:hexane = 4:1 or diethyl ether eluates amidines 4, 5 were obtained.
N-(2-Bromo-3-chloropropyl)-N’-(trifluoromethylsulfonyl)acetamidamide, 4. Yield 0.7 g, 43.2%. Oil. 1H NMR (400 MHz, CDCl3) δ 6.85 (s, 1H, NH), 4.35 (ddd, J = 12.5, 8.3, 4.1 Hz, 1H, CHBr), 4.15 (ddd, J = 14.5, 5.9, 4.1 Hz, 1H, CHAHNH), 3.93 (dd, J = 11.8, 4.1 Hz, 1H, CHHBNH), 3.76 (dd, J = 11.9, 8.3 Hz, 1H, CHAHCl), 3.68 (ddd, J = 14.5, 8.3, 5.9 Hz, 1H, CH2Cl), 2.53 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 169.5 (C=NTf), 121.4 (q, J = 319.4 Hz, CF3), 48.3 (CHBr), 46.6 (CH2NH), 45.6 (CH2Cl), 22.1 (CH3). 19F NMR (376 MHz, CDCl3) δ −78.99. IR (thin): 3334 (NH), 3137, 2928, 1719, 1566 (C=N), 1430, 1323, 1213, 1198 (CF3), 1136, 1086, 1055, 929, 775, 745, 663 (C–Br), 601, 542, 474. HRMS (ESI): m/z: [M+H]+ calcd for C6H9BrClF3N2O2S: 343,92087; found [M+H]+: 344.92869.
N-(2,3-Dibromopropyl)-N’-(trifluoromethylsulfonyl)acetamidamide,5. Yeild 1.1 g, 60.1%. Oil. 1H NMR (400 MHz, CDCl3) δ 7.14 (s, 1H, NH), 4.38 (tt, J = 8.6, 4.1 Hz, 1H, CHBr), 4.20 (ddd, J = 14.6, 6.0, 3.9 Hz, 1H, CH2NH), 3.83 (dd, J = 10.9, 4.3 Hz, 1H, CH2NH), 3.65 (m, 2H, CH2Br), 2.52 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ169.7 (C=NTf), 121.4 (q, J = 319.6 Гц, CF3), 47.7 (CHBr), 47.4 (CH2NH), 32.8 (CH2Br), 21.9 (CH3). IR (thin): 3335, 3227 (NH), 3136, 2943, 1774, 1721, 1580, 1562 (C=N), 1428, 1373, 1323, 1278, 1215, 1197 (CF3), 1135, 1081, 1053, 914, 833, 775, 746, 665, 602 (C–Br), 548, 476. 19F NMR (376 MHz, CDCl3) δ −78.86. Anal. calcd. for (C6H9Br2F3N2O2S): C, 18.48; H, 2.33; F, 14.61; N, 7.18; S, 8.22. Found: C, 18.88; H, 2.60; F, 15.00; N, 7.53; S, 8.56.
3.2.2. Reactions of Allyl Halides with Triflamide in the Presence NIS + MeCN
To the solution of 1 g (6.7 mmol) of triflamide and 6.7 mmol of allyl halide 1, 2 in 30 mL of acetonitrile added 1.53 g (6.7 mmol) of NIS and reaction mixture was stirred in the dark for 24 h. Solvent was removed in vacuum, then the succinimide was precipitated with diethyl ether, mixture were cooled and succinimide was filtered off, ether removed in a vacuum. Analytically pure samples of substances were separated by column chromatography (0.063–0.2 mm, Acros Organics, Waltham, MA, USA). From the hexane–ether = 1:1 eluate, not reacted triflamide and dibromides were isolated, and from the diethyl ether:hexane = 4:1 or diethyl ether eluates amidines 8, 9 were obtained.
N-(2-Iodo-3-chloropropyl)-N’-(trifluoromethylsulfonyl)acetamidamide, 8. Yield 0.65 g, 41.4%. Oil. 1H NMR (400 MHz, CDCl3) δ 6.96 (s, 1H, NH), 4.44 (ddd, J = 12.9, 8.6, 4.4 Hz, 1H, CHI), 4.05 (dd, J = 9.9, 4.7 Hz, 1H, CHAHNH), 4.00 (dd, J = 11.7, 4.4 Hz, 1H, CHHBNH), 3.81 (dd, J = 11.7, 9.9 Hz, 1H, CHAHCl), 3.71 (ddd, J = 14.4, 8.6, 6.2 Hz, 1H, CHHBCl), 2.52 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 169.4 (C=NTf), 121.3 (q, J = 319.59 Гц, CF3), 48.0 (CH2NH), 47.5 (CH2Cl), 26.1 (CHI), 22.1 (CH3). 19F NMR (376 MHz, CDCl3) δ −78.91. IR (thin): 3326, 3231 (NH), 3080, 2928, 2859, 1723, 1664, 1577, 1553 (C=N), 1428, 1371, 1322, 1215, 1197 (CF3), 1140, 1082, 1050, 939, 846, 774, 745, 708, 662 (C–I), 636, 600, 528, 475. Anal. calcd. for (C6H9ClF3IN2O2S): C, 18.36; H, 2.31; F, 14.52; N, 7.14; S, 8.17; Found: C, 18.50; H, 2.71; F, 15.07; N, 7.53; S, 9.03.
N-(3-Bromo-2-iodopropyl)-N’-(trifluoromethylsulfonyl)acetamidamide, 9. Yield: 0.41 g, 27.5%. Oil. 1H NMR (400 MHz, CDCl3) δ 7.43 (br.s, 1H, NH), 4.60–4.43 (m, 1H, CHI), 4.14–3.94 (m, 2H, CH2NH), 3.78–3.65 (m, 2H, CH2Br), 2.53 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 169.5 (C=NTf), 121.3 (q, J = 319.4 Hz, CF3), 48.9 (CH2NH), 35.1 (CH2Br), 25.8 (CHI), 22.1 (CH3). 19F NMR (376 MHz, CDCl3) δ −78.81. IR (thin): 3325, 3241 (NH), 3093, 3036, 2927, 2852, 1727, 1650, 1586, 1555 (C=N), 1428, 1375 (SO2), 1321, 1268, 1211, 1195 (CF3), 1139, 1081, 1049, 1007, 970, 945, 912, 811, 775, 740, 662, 639, 604, 580, 527, 475. Anal. calcd. for (C6H9BrF3IN2O2S) C, 16.49; H, 2.08; F, 13.04; N, 6.41; S, 7.34. Found: C, 16.50; H, 2.19; F, 12.73; N, 6.18; S, 7.59.
3.2.3. Reaction of Allyl Alcohol with Triflamide in the NBS + MeCN System
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.39 g (6.7 mmol) of allyl alcohol 4 in 25 mL of acetonitrile was added 1.19 g (6.7 mmol) of NBS, and the reaction mixture was kept in the dark for 24 h. The solvent was removed under reduced pressure, the residue was dissolved in 20 mL of diethyl ether, cooled and the formed succinimide was filtered off. The filtrate was evaporated in vacuum, the residue (1.79 g) was placed on a silica gel column (0.063–0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with ether:hexane = 1:1 mixture, isolating unreacted triflamide (~0.4 g), then with ether, obtaining N-(2-bromo-3-hydroxypropyl)-N’-(trifluoromethylsulfonyl)acetamidamide 12 as a colorless oil.
N-(2-Bromo-3-hydroxypropyl)-N’-(trifluoromethylsulfonyl)acetamidamide, 12. Yield 0.34 g, 26%. The product was obtained earlier and described in [
16].
3.2.4. Reaction of Allyl Cyanide with Triflamide in the System NBS+MeCN
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.45 g (6.7 mmol) of allyl cyanide in 40 mL of acetonitrile was added 1.19 g (6.7 mmol) of NBS, and the reaction mixture kept in the dark for 24 h. The solvent was removed under reduced pressure, the residue dissolved in 40 mL of diethyl ether, kept in a refrigerator and the formed succinimide filtered off. The filtrate was evaporated in a vacuum, the residue (~1.81 g) was placed on a silica gel column (0.063–0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with ether:hexane (1:1) to give unreacted triflamide (0.2 g), then with ether to afford 1.08 g N-(2-bromo-3-cyanopropyl)-N’-(triflyl)acetimidamide 14 as a yellow oil.
N-(2-Bromo-3-cyanopropyl)-N’-(trifluoromethylsulfonyl)acetimidamide, 14. Oil. Yield 60%. 1H NMR (400 MHz, CDCl3) δ 7.21 (br t, J = 5.6 Hz, 1H, NH), 4.36 (ddd, J = 11.1, 7.1, 5.6 Hz, 1H, CHBr), 3.90 (ddd, J = 14.4, 5.6, 5.6 Hz, 1H, CHAN), 3.80 (ddd, J = 14.4, 7.1, 5.6 Гц, 1H, CHBN), 3.04 (dd, J = 5.6, 2.6 Гц, 2H, CH2CN), 2.54 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 170.2 (C=NTf), 121.4 (q, J = 320.0 Hz, CF3), 115.9 (C≡N), 48.0 (CH2N), 41.8 (CHBr), 25.8 (CH2CN), 21.9 (CH3). 19F NMR (376 MHz, CDCl3) δ −78.88. IR (thin): 3324 (NH), 3135, 3025, 2952, 2933, 2259 (C≡N), 1711, 1560 (NHC=N), 1430, 1325, 1195, 1139, 1049, 747, 659 (C–Br), 600, 475. HRMS (ESI): m/z: [M+H]+ calcd for C7H9BrF3N3O2S+: 335.962919; found: 335.962880.
3.2.5. Reaction of Allyl Cyanide with Triflamide in the System NBS + CH2Cl2
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.45 g (6.7 mmol) of allyl cyanide in 40 mL of CH2Cl2 was added 1.19 g (6.7 mmol) of NBS. The reaction was carried out for 24 h in the dark. Then, the solvent was removed under reduced pressure, the residue was dissolved in 40 mL of diethyl ether, placed in a refrigerator for 1 h, and the formed succinimide was filtered off. The ether fraction was evaporated in vacuum, the residue (~2.21 g) was placed on a silica gel column (0.063–0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with hexane to give 3,4-dibromobutanenitrile 19 (0.40 g, 26%), followed by ether:hexane = 1:1, isolating unreacted triflamide (0.6 g), then with ether:hexane (4:1) to afford 3-bromo-4-hydroxybutanenitrile 20 (0.20 g, 18%), and hexane:chloroform:ether (1:2:2) to obtained N-(2-bromo-3-cyanopropyl)triflamide 15 (0.15 g, 19%) and N-(1-bromo-3-cyanoprop-2-yl)triflamide 18 (0.10 g, 13%).
N-(2-Bromo-3-cyanopropyl)trifluoromethanesulfonamide, 15. Yield 19%. Oil. 1H NMR (400 MHz, CDCl3) δ 6.03 (t, J = 5.5 Hz, 1H, NH), 4.18–4.09 (m, 1H, CHBr), 3.67–3.57 (m, 2H, CH2N), 2.92 (t, J = 6.0 Hz, 2H, CH2CN). 13C NMR (100 MHz, CDCl3) δ 119.3 (q, J = 320.1 Hz, CF3), 115.3 (C≡N), 49.0 (CH2NH), 43.1 (CHBr), 23.4 (CH2CN). 19F NMR (376 MHz, CDCl3) δ −77.23. IR (thin): 3199 (NH), 2923, 2259 (C≡N), 1723, 1615, 1454, 1440, 1380 (SO2), 1230 (CF3), 1197, 1145, 1098, 1067, 1045, 974, 924, 891, 829, 763, 677, 610, 587, 518. Anal. calcd. for (C5H6BrF3N2O2S): C, 20.35; H, 2.05; N, 9.49; Br, 27.08; S, 10.87. Found: C, 20.13; H, 2.10; N, 9.98; Br, 27.18; S 10.12.
N-(1-Bromo-3-cyanopropan-2-yl)trifluoromethanesulfonamide, 18. Yield 13%. Oil. 1H NMR (400 MHz, CDCl3) δ 6.17 (d, J = 7.9 Hz, 1H, NH), 4.23 (quint, J = 6.3 Hz, 1H, CHNH), 3.71 (t, J = 6.0 Hz, 2H, CH2Br), 3.09 (d, J = 5.7 Hz, 2H, CH2CN). 13C NMR (100 MHz, CDCl3) δ 119.5 (q, J = 321.0 Hz, CF3), 115.8 (C≡N), 51.8 (CHN), 33.5 (CH2Br), 25.1 (CH2CN). 19F NMR (376 MHz, CDCl3) δ −76.8.
3,4-Dibromobutanenitrile, 19. Yield 26%. Oil. 1H NMR (400 MHz, CDCl3) δ 4.18 (ddd, J = 11.8, 6.2, 5.2 Hz, 1H, CHBr), 3.94 (dd, J = 11.8, 5.2 Hz, 1H, CHAHBr), 3.86 (dd, J = 11.8, 6.2 Hz, 1H, CHHBBr), 3.11 (dd, J = 17.2, 5.2 Hz, 1H, CHAHCN), 3.05 (dd, J = 17.2, 6.2 Hz, 1H, CHHBCN). 13C NMR (100 MHz, CDCl3) δ 116.6 (C≡N), 65.4 (CHBr), 46.1 (CH2Br), 24.2 (CH2C≡N). IR (thin): 3420, 2957, 2928, 2883, 2257 (C≡N), 2066, 1773, 1723, 1649, 1636, 1625, 1577, 1562, 1546, 1457, 1413, 1379, 1343, 1289, 1198, 1149, 1088, 1060, 1028, 976, 942, 916, 876, 846, 724, 645 (C–Br), 607, 539. Anal. calcd. for C4H5Br2N: C, 21.17; H, 2.22; Br, 70.43; N, 6.17. Found: C, 21.10; H, 2.11.
3-Bromo-4-hydroxybutanenitrile,20. Yield 18%. Oil. 1H NMR (400 MHz, CDCl3) δ 4.17 (ddd, J = 12.1, 6.0, 5.5 Hz, 1H, CHBr), 3.93 (dd, J = 12.1, 5.5 Hz, 1H, CHAHBr), 3.85 (dd, J = 12.1, 6.0 Hz, 1H, CHHBBr), 3.10 (dd, J = 17.3, 5.5 Hz, 1H, CHAHCN), 3.04 (dd, J = 17.3, 6.6 Hz, 1H, CHHBCN), 2.59 (br.s, 1H, OH). 13C NMR (100 MHz, CDCl3) δ 116.7 (C≡N), 65.3 (CH2OH), 46.0 (CHBr), 24.2 (CH2C≡N). IR (thin): 3430, 2962, 2928, 2256, 1783, 1725, 1613, 1543, 1453, 1413, 1380, 1350, 1285, 1228, 1198, 1148, 1087, 1058, 1029, 976, 944, 917, 863, 822, 727, 672, 645, 608, 580, 537, 512. Anal. calcd. for C4H6BrNO: C, 29.20; H, 3.40; Br, 48.00; N, 9.51. Found: C, 29.29; H, 3.69; Br, 48.72; N, 8.54.
3.2.6. Reaction of Allyl Chloride with Triflamide in the NBS + THF System
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.51 g (6.7 mmol) of allyl chloride
1 in 30 mL of tetrahydrofuran was added 1.19 g (6.7 mmol) of NBS, and the reaction mixture was kept in the dark for 24 h. The solvent was removed under reduced pressure, the residue was dissolved in 20 mL of diethyl ether, mixture was cooled and succinimide was filtered off. The filtrate was evaporated in vacuo, the residue (~2.20 g) was placed on a silica gel column (0.063–0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with ether:hexane = 1:1 mixture, isolating unreacted triflamide, then with ether, obtaining 0.30 g of 1,2- dibromo-3-chloropropane
16 as a yellow oil. Product
16 was obtained and described earlier [
26].
3.2.7. Reaction of Allyl Cyanide with Triflamide in the System NBS + THF
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.45 g (6.7 mmol) of allyl cyanide in 40 mL of THF 1.19 g (6.7 mmol) of NBS was added. The reaction was carried out for 24 h in the dark. The solvent was removed under reduced pressure, the residue dissolved in 40 mL of diethyl ether, placed in a refrigerator for 1 h, and the formed succinimide was filtered off. The ether fraction was evaporated in vacuum, and the residue (~2.21 g) was placed on a silica gel column (0.063–0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with ether:hexane (1:1), isolating unreacted triflamide (0.4 g), then with ether:hexane (4:1) to give N-(4-(2-bromo-3-cyanopropoxy)butyl)triflamide 17 (1.16 g, 79%).
N-(4-(2-Bromo-3-cyanopropoxy)butyl)trifluoromethanesulfonamide,17. (45%). Oil. 1H NMR (400 MHz, CD3CN) δ 5.86 (s, 1H, NH), 4.24–4.07 (m, 1H, CHBr), 3.85–3.72 (m, 1H, CHBrCHAHO), 3.72–3.61 (m, 1H, CHBrCHHBO), 3.61–3.37 (m, 4H), 3.36–3.22 (m, 1H), 3.08–3.00 (m, 1H), 1.79–1.55 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 119.7 (q, J = 321.3 Hz, CF3), 116.6 (C≡N), 73.0 (CHBrCH2O), 70.9 (CH2CH2O), 44.0 (CHBr), 41.8 (CH2NH), 27.1 (CHBr), 26.2 (CH2CH2), 26.63 (CH2CH2), 24.6 (CH2C≡N). 19F NMR (376 MHz, CDCl3) δ −77.21. IR (thin): 3304, 3221 (NH), 2946, 2876, 2258 (C≡N), 1652, 1452, 1439, 1420, 1373 (SO2), 1284, 1230 (CF3), 1192, 1148, 1078, 990, 920, 877, 812, 742, 609, 579, 511. Anal. calcd. for C9H14BrF3N2O3S: C, 29.44; H, 3.84; N, 7.63; Br, 21.76; found: C, 29.90; H, 3.52; N, 7.42; Br, 21.90.
3.2.8. Reaction of N-(2-bromo-3-chloropropyl)-N’-(trifluoromethylsulfonyl)acetamidamide 4 with K2CO3 in MeCN
To a solution of amidine 4 0.2 g (0.6 mmol) in acetonitrile (10 mL) was added a 2-fold excess of potassium carbonate 0.17 g (1.2 mmol) and stirred for 4 h. The precipitate in the form of salt was filtered off, the acetonitrile fraction was distilled off under reduced pressure, obtaining 0.13 g of 5-(chloromethyl)-2-methyl-1-((trifluoromethyl)sulfonyl)-4,5- dihydro-1H-imidazole 21 as a colorless oil.
5-(Chloromethyl)-2-methyl-1-(trifluoromethylsulfonyl)-4,5-dihydro-1H-imidazole,21. Yield 0.13 g, 81.3%. 1H NMR (400 MHz, CDCl3) δ 4.64-4.49 (m, 1H, CHN), 4.07 (d.d.d, J = 16.0, 9.3, 1.9 Hz, 1H, CHAHN), 3.95 (dd, J = 16.0, 1.8 Hz, 1H, CHHBN), 3.73 (dd, J = 11.5, 6.1 Hz, 1H, CHAHCl), 3.67 (dd, J = 11.5, 3.1 Hz, 1H, CHHBCl), 2.29 (br. t, J = 1.6 Hz, 3H, CH3).). 13C NMR (100 MHz, CDCl3) δ 153.5 (C=N), 118.64 (q, J = 322.64 Гц, CF3), 61.0 (CHN), 57.5 (CH2N), 46.1 (CH2Cl), 16.3 (CH3). 19F NMR (376 MHz, CDCl3) δ −74.834. IR (thin): 2947, 2879, 2856, 2622, 1723, 1676, 1438, 1404, 1388 (SO2), 1352, 1312, 1283, 1239, 1207 (CF3), 1157, 1101, 1075, 1058, 1023, 1003, 939, 898, 872, 784, 767, 736, 681, 666, 621, 592, 536, 505. Anal. calcd. For (C6H8ClF3N2O2S): C, 27.23; H, 3.05; F, 21.54; N, 10.59; S, 12.11. Found: C, 27.42; H, 3.15; F, 21.67; N, 10.70; S, 12.23.
3.2.9. Reaction of N-(2,3-dibromopropyl)-N’-((trifluoromethyl)sulfonyl)acetamidamide 5 with K2CO3 in MeCN
To a solution of amidine 5 0.16 g (0.4 mmol) in acetonitrile (10 mL) was added a 2-fold excess of potassium carbonate 0.11 g (0.8 mmol) and stirred for 4 h. The precipitate in the form of salt was filtered off, the acetonitrile fraction was distilled off under reduced pressure, obtaining 5-(bromomethyl)-2-methyl-1-((trifluoromethyl)sulfonyl)-4,5-dihydro- 1H-imidazole 22 as a colorless oil.
5-(Bromomethyl)-2-methyl-1-(trifluoromethylsulfonyl)-4,5-dihydro-1H-imidazole, 22. Yield 0.11 g, 91.7%. Oil. 1H NMR (400 MHz, CDCl3) δ 4.59–4.49 (m, 1H, CHN), 4.07 (d.d.d, J = 16.0, 9.4, 2.1 Hz, 1H, CHAHN), 3.90 (d.d.d, J = 16.0, 3.3, 2.1 Hz, 1H, CHHBN), 3.57-3.52 (m, 2H, CH2Br), 2.27 (br. t, J = 1.6 Hz, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 153.4 (C=N), 121.79 (q, J = 324.2 Гц, CF3), 60.7 (CHN), 58.5 (CH2N), 34.7 (CH2Br), 16.4 (CH3). 19F NMR (376 MHz, CDCl3) δ -74.77. IR (thin): 2945, 2878, 2606, 1675, 1437, 1404, 1388 (SO2), 1347, 1305, 1238, 1206 (CF3), 1156, 1099, 1073, 1054, 1012, 992, 936, 889, 862, 771, 692, 672, 659,641, 613, 590, 574, 535, 477, 416. Anal. calcd. For C6H8BrF3N2O2S: C, 23.31; H, 2.61; F, 18.44; N, 9.06; S, 10.37. Found: C, 23.42; H, 2.71; F, 18.55; N, 9.13; S, 10.42.
3.2.10. Hydrolysis of 5-(bromomethyl)-2-methyl-1-(trifluoromethylsulfonyl)-4,5-dihydro- 1H-imidazole 22
Compound 17 0.11 mg (0.36 mmol) was subjected to hydrolysis with the formation of N-(3-bromo-2-((trifluoromethyl)sulfonamido)propyl)acetamide 23.
N-(3-Bromo-2-((trifluoromethyl)sulfonamido)propyl)acetamide, 23. Yield 0.10 g, 83.3%. 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 7.3 Hz, 1H, CHNH), 6.33 (t, J = 4.8 Hz 1H, CH2NH), 3.96–3.87 (m, 1H, CHNH), 3.69–3.60 (m, 2H, CH2NH), 3.44 (dd, J = 10.9, 7.9 Hz, 2H, CH2Br), 2.05 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 173.6 (C=O), 121.67 (q, J = 320.94 Гц, CF3), 56.0 (CHN), 42.5 (CH2N), 32.7 (CH2Br), 22.9 (CH3). 19F NMR (376 MHz, CDCl3) δ −77.15. IR (thin): 3352 (NH), 3119 (NH), 2957, 2922, 2853, 2255, 1656 (C=O), 1561, 1547, 1431, 1377 (SO2), 1324, 1199 (CF3), 1141, 1052, 984, 909, 735, 651, 614, 476. Anal. calcd. For (C6H10BrF3N2O3S): C, 22.03; H, 3.08; F, 17.42; N, 8.56; S, 9.80. Found: C, 22.19; H, 3.22; F, 17.54; N, 8.63; S, 9.91.
3.2.11. Reaction of N-(2-bromo-3-cyanopropyl)-N’-(triflyl)acetimidamide 14 with Base in Acetonitrile
To a solution of amidine 14 (0.27 g, 0.8 mmol) in acetonitrile (10 mL), 2-fold excess of a base (potassium carbonate or triethylamine) was added and stirred for 2 h. The formed salt was filtered off, the acetonitrile fraction was distilled off in a vacuum, affording N-(3-cyanoallyl)-N’-((trifluoromethyl)sulfonyl)acetimidamide 25 (0.19 g, 93%),
N-(3-Cyanoallyl)-N’-(trifluoromethyl)sulfonyl)acetimidamide,25. Yield 93%. Oil. 1H NMR (400 MHz, CD3CN) δ 7.92 (br s, 1H, NH), 6.49 (dt, J = 11.2, 6.0 Hz, 1H, =CHCH2), 5.63 (dt, J = 11.2, 1.4 Hz, 1H, =CHC≡N), 4.20 (td, J = 6.0, 1.4 Hz, 2H, CH2N), 2.40 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 171.0 (C=NTf), 148.4 (=CHNH); 121.09 (q, J = 319.2 Hz, CF3), 116.0 (C≡N), 102.5 (=CHCH2), 43.4 (CH2); 21.8 (CH3). 19F NMR (376 MHz, CDCl3) δ −79.03. IR (thin): 3323, 3133 (NH), 3082, 2944, 2259 (C≡N), 2228, 1772, 1715, 1661, 1588, 1561, 1427, 1384 (SO2), 1354, 1329, 1279, 1216 (CF3), 1195, 1141, 1102, 1081, 1068, 1042, 975, 920, 901, 871, 843, 776, 739, 604, 584, 537, 475, 435. HRMS (ESI): m/z: [M+H]+ calcd for C7H8F3N3O2S+: 256.036757; found: 256.036460.
3.2.12. Reaction of Allyl Cyanide with Triflamide in the System NBS + MeCN + K2CO3
To a solution of 1.00 g (6.7 mmol) of triflamide and 0.45 g (6.7 mmol) of allyl cyanide in 40 mL of CH3CN was added 1.19 g (6.7 mmol) of NBS. The reaction was carried out for 24 h in the dark. Then, 1.85 g (13.4 mmol) of K2CO3 was added and stirred for another 3 h. The precipitate was filtered off, the solvent removed under reduced pressure, the black residue (~2.43 g) was placed on a silica gel column (0.063-0.2 mm, Acros Organics, Waltham, MA, USA) and eluted with ether:hexane (4:1) giving N-(3-cyanoprop-1-en-1-yl)-N’-(trifluoromethyl- sulfonyl)acetimidamide 26 (1.30 g, 75%).
N-(3-Cyanoprop-1-en-1-yl)-N’-(trifluoromethylsulfonyl)acetimidamide,26. Yield 75%. Oil. 1H NMR (400 MHz, CDCl3) δ 8.66 (br. s, 1H, NH), 6.94 (t, J = 8.8 Hz, 1H, =CHCN), 5.06 (dd, J = 16.0, 7.5 Hz, 1H, =CH), 3.28 (dd, J = 7.5, 1.3 Hz, 2H, CH2), 2.56 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 166.9 (C=NTf), 125.4 (=CHCH2), 119.2 (q, J = 318.8 Hz, CF3); 117.3 (NC), 104.5 (=CHCN); 29.6 (CH2NH); 21.6 (CH3). 19F NMR (376 MHz, CDCl3) δ −79.01. IR (thin): 3330, 3120 (NH), 3079, 2958, 2929, 2860, 2256 (C≡N), 2230, 1774, 1711, 1680, 1653, 1576, 1541, 1431, 1381 (SO2), 1326, 1267, 1215 (CF3), 1194, 1140, 1049, 950, 907, 838, 785, 753, 683, 643, 615, 581, 534, 497.
3.2.13. Reaction of N-(4-(2-bromo-3-cyanopropoxy)butyl)triflamide 17 with a Base in Acetonitrile
To a solution (0.20 g, 0.05 mmol) of N-(4-(2-bromo-3-cyanopropoxy)butyl)triflamide 10 in acetonitrile (10 mL) was added a 2-fold excess of potassium carbonate (0.01 g, 0.1 mmol) and stirred for 4 h. The precipitated salt was filtered off, the acetonitrile fraction was distilled off in a vacuum to afford N-(4-((3-cyanoprop-1-en-1-yl)oxy)butyl)triflamide 27 and N-(4-(3-cyanolyl)oxy)butyl)triflamide 28 in the ratio of 1:2.
N-(4-(3-Cyanoprop-1-en-1-yl)oxy)butyl)trifluoromethanesulfonamide, 27; N-(4-((3-cyanoallyl)oxy)butyl)trifluoromethanesulfonamide, 28. Oil. 1H NMR (400 MHz, CD3CN) δ 6.74 (comp. 11; dt, J = 16.2, 3.8 Hz, 1H, =CHO), 6.57 (comp. 12; dt, J = 11.3, 5.6 Hz, 1H, =CHCH2O), 5.87 (comp. 12; br s, 1H, NH), 5.64 (comp. 11; d, J = 16.2, 1H, CH2CH=CHO), 5.51 (comp. 12; d, J = 11.3, 1H, NCCH=), 5.45 (comp. 11; br s, 1H, NH), 4.38–4.26 (comp. 12; m, 2H, OCH2CH2), 4.18–4.09 (comp. 11; m, 2H, OCH2CH2), 3.64–3.25 (11 + 12, m), 1.90–1.60 (11 + 12, m). 13C NMR (100 MHz, CDCl3) δ 150.2, 149.6 (OCH=); 118.6, 118.2 (C≡N); 101.1, 100.2 (=CH); 70.9, 70.7, 69.4, 69.1 (OCH2); 44.3, 44.2 (CH2NH); 27.57, 27.50, 26.67, 26.50. 19F NMR (376 MHz, CDCl3) δ −77.18. Anal. calcd. for C9H13F3N2O3S: C, 37.76; H, 4.58; F, 19.91; N, 9.79; S, 11.20; found: C, 39.02; H, 4.95; F, 21.71; N, 9.02; S, 11.90.